CoChat

TBC1D24 genotype–phenotype correlation: Epilepsies and other neurologic features

Open access

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate the phenotypic spectrum associated with mutations in TBC1D24. METHODS: We acquired new clinical, EEG, and neuroimaging data of 11 previously unreported and 37 published patients. TBC1D24 mutations, identified through various sequencing methods, can be found online (http://lovd.nl/TBC1D24). RESULTS: Forty-eight patients were included (28 men, 20 women, average age 21 years) from 30 independent families. Eighteen patients (38%) had myoclonic epilepsies. The other patients carried diagnoses of focal (25%), multifocal (2%), generalized (4%), and unclassified epilepsy (6%), and early-onset epileptic encephalopathy (25%). Most patients had drug-resistant epilepsy. We detail EEG, neuroimaging, developmental, and cognitive features, treatment responsiveness, and physical examination. In silico evaluation revealed 7 different highly conserved motifs, with the most common pathogenic mutation located in the first. Neuronal outgrowth assays showed that some TBC1D24 mutations, associated with the most severe TBC1D24-associated disorders, are not necessarily the most disruptive to this gene function. CONCLUSIONS: TBC1D24-related epilepsy syndromes show marked phenotypic pleiotropy, with multisystem involvement and severity spectrum ranging from isolated deafness (not studied here), benign myoclonic epilepsy restricted to childhood with complete seizure control and normal intellect, to early-onset epileptic encephalopathy with severe developmental delay and early death. There is no distinct correlation with mutation type or location yet, but patterns are emerging. Given the phenotypic breadth observed, TBC1D24 mutation screening is indicated in a wide variety of epilepsies. A TBC1D24 consortium was formed to develop further research on this gene and its associated phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002807

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Genetic and phenotypic heterogeneity The diagram illustrates the exonic structure of TBC1D24 isoform 1 (NM_001199107.1), with the introns as thin lines not drawn to scale. The noncoding exonic regions are drawn in gray, and the coding regions thicker and in color (orange for Rab GTPase-activating protein [Rab-GAP] domain, blue for TLDc domain, and yellow for the rest). The location of the mutations identified in various epilepsy syndromes is shown, according to the severity of the epilepsy phenotype. No clear pattern of genotype–phenotype correlation emerges. Circle = myoclonic epilepsy; square = generalized epilepsy; triangle = focal epilepsy; diamond = early-onset epileptic encephalopathy; hexagon = unclassified epilepsy. Black = death; red = drug-resistant epilepsy; blue = drug-responsive epilepsy or seizure-free. D = DOORS syndrome. Black arrows = missense mutations; red arrows = frameshift mutations; gray arrows = nonsense mutations; blue arrows = splice-site mutations; * = recurrent mutations.
Figure 1 Genetic and phenotypic heterogeneity The diagram illustrates the exonic structure of TBC1D24 isoform 1 (NM_001199107.1), with the introns as thin lines not drawn to scale. The noncoding exonic regions are drawn in gray, and the coding regions thicker and in color (orange for Rab GTPase-activating protein [Rab-GAP] domain, blue for TLDc domain, and yellow for the rest). The location of the mutations identified in various epilepsy syndromes is shown, according to the severity of the epilepsy phenotype. No clear pattern of genotype–phenotype correlation emerges. Circle = myoclonic epilepsy; square = generalized epilepsy; triangle = focal epilepsy; diamond = early-onset epileptic encephalopathy; hexagon = unclassified epilepsy. Black = death; red = drug-resistant epilepsy; blue = drug-responsive epilepsy or seizure-free. D = DOORS syndrome. Black arrows = missense mutations; red arrows = frameshift mutations; gray arrows = nonsense mutations; blue arrows = splice-site mutations; * = recurrent mutations.CC BY · PubMed Central
Figure 2 Disease-causing mutations in evolutionarily conserved motifs (A) Seven highly conserved motifs are identified in TBC1D24/Sky in an interspecies comparison against related Tre2/Bub2/Cdc16 (TBC) domain proteins. The Rab GTPase-activating protein (Rab-GAP) TBC domain is drawn in orange, the TLDc domain is drawn in blue, and the rest is in yellow, as in figure 1. (B) The consensus sequence of the TBC domain motif 2 contains an arginine residue (*) that is substituted in the most frequent pathogenic mutation seen in patients with deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures. Further residues affected by pathogenic mutations are indicated by an asterisk above the residue. (C) Motif 1 in the TBC domain, motif 3 in the region between the TBC and TLDc domains, as well as motifs 4 and 7 in the TLDc domain contain further residues affected by pathogenic mutations, as indicated by an asterisk.
Figure 2 Disease-causing mutations in evolutionarily conserved motifs (A) Seven highly conserved motifs are identified in TBC1D24/Sky in an interspecies comparison against related Tre2/Bub2/Cdc16 (TBC) domain proteins. The Rab GTPase-activating protein (Rab-GAP) TBC domain is drawn in orange, the TLDc domain is drawn in blue, and the rest is in yellow, as in figure 1. (B) The consensus sequence of the TBC domain motif 2 contains an arginine residue (*) that is substituted in the most frequent pathogenic mutation seen in patients with deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures. Further residues affected by pathogenic mutations are indicated by an asterisk above the residue. (C) Motif 1 in the TBC domain, motif 3 in the region between the TBC and TLDc domains, as well as motifs 4 and 7 in the TLDc domain contain further residues affected by pathogenic mutations, as indicated by an asterisk.CC BY · PubMed Central
Figure 3 Neurite outgrowth associated with TBC1D24 mutants Primary mouse cortical cells were transfected with wild-type (WT) or mutant TBC1D24 constructs as indicated and representative images of transfected neurons are shown. Quantification of neurite length shows that expression of Arg242Cys (R242C) and Arg360Leu (R360L), but not Arg40Leu (R40L) or Arg270Cys (R270C), results in a significantly reduced induction of outgrowth compared to WT. ***p < 0.001, 1-way analysis of variance; scale bar = 10 μM.
Figure 3 Neurite outgrowth associated with TBC1D24 mutants Primary mouse cortical cells were transfected with wild-type (WT) or mutant TBC1D24 constructs as indicated and representative images of transfected neurons are shown. Quantification of neurite length shows that expression of Arg242Cys (R242C) and Arg360Leu (R360L), but not Arg40Leu (R40L) or Arg270Cys (R270C), results in a significantly reduced induction of outgrowth compared to WT. ***p < 0.001, 1-way analysis of variance; scale bar = 10 μM.CC BY · PubMed Central
Figure 4 Phenotypic spectrum of patients with TBC1D24 mutation The graph displays the age at epilepsy onset along the horizontal axis, the categorical outcome varying from seizure control to death along the vertical axis. The degree of intellectual disability is represented by the different fill of the circles, varying from white to black.
Figure 4 Phenotypic spectrum of patients with TBC1D24 mutation The graph displays the age at epilepsy onset along the horizontal axis, the categorical outcome varying from seizure control to death along the vertical axis. The degree of intellectual disability is represented by the different fill of the circles, varying from white to black.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 127

Metadata

Authors
Balestrini, S., Milh, M., Castiglioni, C., Lüthy, K., Finelli, M. J., Verstreken, P., Cardon, A., Stražišar, B. G., Holder, J. L., Lesca, G., Mancardi, M. M., Poulat, A. L., Repetto, G. M., Banka, S., Bilo, L., Birkeland, L. E., Bosch, F., Brockmann, K., Cross, J. H., Doummar, D., Félix, T. M., Giuliano, F., Hori, M., Hüning, I., Kayserili, H., Kini, U., Lees, M. M., Meenakshi, G., Mewasingh, L., Pagnamenta, A. T., Peluso, S., Mey, A., Rice, G. M., Rosenfeld, J. A., Taylor, J. C., Troester, M. M., Stanley, C. M., Ville, D., Walkiewicz, M., Falace, A., Fassio, A., Lemke, J. R., Biskup, S., Tardif, J., Ajeawung, N. F., Tolun, A., Corbett, M., Gecz, J., Afawi, Z., Howell, K. B., Oliver, K. L., Berkovic, S. F., Scheffer, I. E., de Falco, F. A., Oliver, P. L., Striano, P., Zara, F., Campeau, P. M., & Sisodiya, S. M.
Affiliations
  • Génétique Médicale & Génomique Fonctionelle (FR)
  • St Mary's Hospital (GB)
  • University of Göttingen (DE)
  • Hôpital Armand-Trousseau (FR)
  • Churchill Hospital (GB)
  • Baylor College of Medicine (US)
  • Hospices Civils de Lyon (FR)
  • Institut de Biologie du Développement Marseille (FR)
  • University of Genoa (IT)
Corresponding author
Sisodiya, S.M.
Venue
Neurology
Published
2016-07-05
Volume
87
Issue
1
Pages
77-85
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2415622914
Cited by
124
References
35
Citations by year
2026: 5 · 2025: 7 · 2024: 17 · 2023: 11 · 2022: 11 · 2021: 19 · 2020: 19 · 2019: 9 · 2018: 15 · 2017: 10 · 2016: 1
FWCI
10.23
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Collections portal (Koç University) (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • Research Explorer (The University of Manchester) (publishedVersion, cc-by)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (acceptedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Lirias (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • Digital Collections portal (Koç University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
Funders
  • March of Dimes Foundation
  • Belgian American Educational Foundation
  • Sanofi
  • University of Wisconsin-Madison
  • Wellcome Trust (628952, 090532, 090532/Z/09/Z, 090532/Z/09/)
  • National Institute for Health and Care Research (NF-SI-0515-10073)
  • Imperial College Healthcare NHS Trust
  • University of Oxford
  • European Commission
  • Institut National de la Santé et de la Recherche Médicale
  • University of Adelaide
  • Georg-August-Universität Göttingen
  • Eisai
  • Great Ormond Street Hospital for Children
  • Universität zu Lübeck
  • Università degli Studi di Genova
  • Clínica Alemana de Santiago
  • CHU Sainte-Justine Foundation
  • Canadian Institutes of Health Research
  • Medical Research Council (G0900747 91070, Hub grant G0900747 91070, MR/J01270X/1)
  • National Health and Medical Research Council
  • Health Research Council of New Zealand
  • FP7 Ideas: European Research Council (311394)
  • Cilag
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
TBC1D24, genotype-phenotype correlation, myoclonic epilepsy, early-onset epileptic encephalopathy, drug-resistant epilepsy, conserved motifs, neurite outgrowth, developmental delay, mutation detection, epilepsy syndromes
MeSH terms
Animals, Brain, Carrier Proteins, Cells, Cultured, Child, Child, Preschool, Electroencephalography, Epilepsy, Female, Humans, Infant, Male, Membrane Proteins, Mutation, Nerve Tissue Proteins, Physical Examination, Cohort Studies, Neurites, GTPase-Activating Proteins, Cell Enlargement, Mice, Young Adult, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TBC1D24 genotype–phenotype correlation: Epilepsies and other neurologic features. https://app.cochat.ai/papers/10.1212/wnl.0000000000002807
The paper
Balestrini, S., Milh, M., Castiglioni, C., Lüthy, K., Finelli, M. J., Verstreken, P., Cardon, A., Stražišar, B. G., Holder, J. L., Lesca, G., Mancardi, M. M., Poulat, A. L., Repetto, G. M., Banka, S., Bilo, L., Birkeland, L. E., Bosch, F., Brockmann, K., Cross, J. H., . . . Sisodiya, S. M. (2016). TBC1D24 genotype–phenotype correlation: Epilepsies and other neurologic features. Neurology. https://doi.org/10.1212/wnl.0000000000002807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.